Phase I Studies Drive 16% Rise In Danish Clinical Trial Applications
Executive Summary
Clinical trial applications in Denmark rose by just under 16% in 2015, driven partly by a doubling in the number of Phase I studies, which the medicines agency attributes to the work of a new public-private partnership aimed at boosting Denmark’s attractiveness as a location for early-phase trials.